CLINICAL_TRIALS
trial_result
· 2014-05-09
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain [Phase 3]
Summary
A Phase 3 trial evaluating ORAVESCENT fentanyl citrate for breakthrough pain in patients with chronic low back pain has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cephalon | Conditions: Chronic Low Back Pain | Phase 3 | Status: COMPLETED